Esther Boudewijns nominated for Albert Schweitzer Prize 2022
Our PhD candidate Esther Boudewijns and her colleague Evelyn Brakema (Leiden University Medical Center) have been nominated for the Albert Schweitzer Prize 2022 with the project 'Cooking should not kill'!
What is the project 'Cooking should not kill' about?
2.6 billion people, a third of the world's population, cook on an open fire. The smoke that is released has a major impact on their health. 3.2 million people die each year as a result. Cleaner cooking solutions are available, but previous attempts to implement them have often been disappointing. There is a lot of knowledge about how implementation can be improved, but that knowledge does not reach the people in the field. Esther and Evelyn have studied factors that can improve the implementation of clean cooking solutions. They have converted the results of this into two practical implementation tools (published in the Lancet Planetary Health). They want to convert these tools into two user-friendly online interactive tools and ensure that the tools are put into use. These tools help the local companies to take into account important factors, such as costs and local needs, when making their implementation plan. This improves implementation success and will ultimately lead to significant health gains.
Vote now!
You can vote for this project until 8 October 2022 via this link: https://www.nasf.nl/inzendingen_asp/koken-mag-niet-doden-20222/
Video
Also read
-
Carlos Mota develops new in vitro models to study kidney diseases at MERLN. For his NEPRHON project, he received the ERC Consolidator Grant.
-
Two researchers from Maastricht University (UM) have received a prestigious ERC Consolidator Grant from the European Research Council. This will allow them to set up a scientific research team in the coming years for studies on bioprinted models of a human kidney and on female guest workers from southern Europe who came to north-western Europe in the second half of the 20th century.
-
Julien was admitted at the last second for the Medicine bachelor. A turning point that led him to research perihilar cholangiocarcinoma, a rare and specific type of bile duct cancer at MUMC+.
